Institutional Manager · CIK 0001652044
Alphabet Inc.
Mountain View, CA · File #028-22702
Latest AUM
$2.58B
Positions
32
Top-10 Concentration
91.8%
Filings
9
Portfolio Value Over Time
2024-03
2024-06
2024-09
2024-12
2025-03
2025-06
2025-09
2025-12
Biggest QoQ Changes
Ranked by conviction flow (share change × current price) so mark-to-market moves don't dominate. Price effect column shows how much of the $ change was just the stock moving.
| Action | Issuer | Ticker / CUSIP | Δ Shares | Flow ($) | Price Effect |
|---|---|---|---|---|---|
| REDUCE | REVOLUTION MEDICINES INC | RVMDW | -4,028,123 | -$320.8M | +$134.5M |
| EXITED | METSERA INC | 59267L107 | -3,783,528 | -$198.0M | $0 |
| ADD | FRESHWORKS INC | FRSH | +12,447,903 | +$152.5M | +$902,097 |
| REDUCE | MAZE THERAPEUTICS INC | MAZE | -1,023,888 | -$42.4M | +$37.4M |
| REDUCE | RELAY THERAPEUTICS INC | RLAY | -1,559,593 | -$13.2M | +$5.1M |
| REDUCE | MONTE ROSA THERAPEUTICS INC | GLUE | -719,067 | -$11.3M | +$12.1M |
| EXITED | DIANTHUS THERAPEUTICS INC | 252828108 | -208,697 | -$8.2M | $0 |
| EXITED | FOGHORN THERAPEUTICS INC | 344174107 | -500,901 | -$2.4M | $0 |
| EXITED | TAYSHA GENE THERAPIES INC | 877619106 | -640,882 | -$2.1M | $0 |
| EXITED | TSCAN THERAPEUTICS INC | 89854M101 | -1,077,080 | -$2.0M | $0 |
Sector Allocation
Filing History
- 13F HOLDINGS REPORTQ/E Dec 202532 pos · $2.58B
- 13F HOLDINGS REPORTQ/E Sep 202540 pos · $2.41B
- 13F HOLDINGS REPORTQ/E Jun 202539 pos · $2.14B
- 13F HOLDINGS REPORTQ/E Mar 202544 pos · $1.58B
- 13F HOLDINGS REPORTQ/E Dec 202444 pos · $1.72B
- 13F HOLDINGS REPORTQ/E Sep 202446 pos · $1.84B
- 13F HOLDINGS REPORTQ/E Jun 202446 pos · $1.97B
- 13F HOLDINGS REPORTQ/E Mar 202447 pos · $2.51B
- 13F HOLDINGS REPORTQ/E Dec 202351 pos · $1.56B
Top 20 Holdings — Dec 2025
| # | Issuer | Ticker | Shares | Value | % of Portfolio |
|---|---|---|---|---|---|
| 1 | AST SPACEMOBILE INC | ASTS | 8,943,486 | $649.6M | 25.18% |
| 2 | PLANET LABS PBC | PL-WT | 31,942,641 | $629.9M | 24.42% |
| 3 | REVOLUTION MEDICINES INC | RVMDW | 3,292,525 | $262.2M | 10.17% |
| 4 | ARM HOLDINGS PLC | 042068205 | 1,960,784 | $214.3M | 8.31% |
| 5 | FRESHWORKS INC | FRSH | 14,327,273 | $175.5M | 6.80% |
| 6 | UIPATH INC | PATH | 7,034,337 | $115.3M | 4.47% |
| 7 | GITLAB INC | GTLB | 2,724,712 | $102.3M | 3.96% |
| 8 | TEMPUS AI INC | TEM | 1,551,102 | $91.6M | 3.55% |
| 9 | DEXCOM INC | DXCM | 1,036,937 | $68.8M | 2.67% |
| 10 | MAZE THERAPEUTICS INC | MAZE | 1,388,583 | $57.5M | 2.23% |
| 11 | PRIME MEDICINE INC | PRME | 16,562,498 | $57.5M | 2.23% |
| 12 | BRIDGEBIO ONCOLOGY THERAPEUT | BBOT | 2,823,126 | $35.3M | 1.37% |
| 13 | FRESHWORKS INC | FRSH | 1,879,370 | $23.0M | 0.89% |
| 14 | RELAY THERAPEUTICS INC | RLAY | 1,564,173 | $13.2M | 0.51% |
| 15 | VERA THERAPEUTICS INC | VERA | 241,264 | $12.2M | 0.47% |
| 16 | MONTE ROSA THERAPEUTICS INC | GLUE | 744,948 | $11.7M | 0.45% |
| 17 | SANA BIOTECHNOLOGY INC | SANA | 2,812,500 | $11.4M | 0.44% |
| 18 | LYELL IMMUNOPHARMA INC | LYEL | 293,256 | $9.0M | 0.35% |
| 19 | BEAM THERAPEUTICS INC | BEAM | 321,604 | $8.9M | 0.35% |
| 20 | FIGMA INC | FIG | 215,582 | $8.1M | 0.31% |